Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Classys Inc. (214150:KRX), powered by AI.
Classys Inc. is currently trading at ₩46,250. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Classys Inc. on Alpha Lenz.
Classys Inc.'s P/E ratio is 22.9.
“Classys Inc. trades at a P/E of 22.9 (fair value) with strong ROE of 26.2%. 3Y revenue CAGR of 33.4% highlights clear growth momentum.”
Ask for details →Classys Inc. is a prominent player in the medical aesthetics industry, specializing in the development and production of non-invasive aesthetic devices. The company's primary function is to innovate and supply equipment used for cosmetic procedures, such as body contouring and skin rejuvenation, which do not require surgical intervention. Classys Inc. stands out in its field by focusing on advanced technological solutions that aim to enhance safety, efficacy, and patient comfort. It impacts sectors including healthcare, beauty, and wellness, catering to a diverse clientele such as medical professionals and cosmetic clinics. Classys Inc.'s role in the market is significant, as it addresses the growing consumer demand for aesthetic enhancements without the associated downtime of traditional surgery. Headquartered in South Korea, Classys Inc. leverages scientific research and development to expand its product portfolio and maintain a competitive edge in the medical technology landscape.
“Classys Inc. trades at a P/E of 22.9 (fair value) with strong ROE of 26.2%. 3Y revenue CAGR of 33.4% highlights clear growth momentum.”
Ask for details →Classys Inc. (ticker: 214150) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 352 employees. Market cap is $3.0T.
The current price is ₩46,250 with a P/E ratio of 22.87x and P/B of 5.46x.
ROE is 26.21% and operating margin is 50.65%. Annual revenue is $336.8B.